High Liner Foods Incorporated (TSX:HLF)
Canada · Delayed Price · Currency is CAD 17.14
+0.20 (1.18%)
Aug 1, 2025, 4:00 PM EDT
Theseus Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 2, 2021 | 2016 - 2020 |
| 950.68 | 959.22 | 1,080 | 1,070 | 875.41 | 827.45 | Upgrade | |
Revenue Growth (YoY) | -7.53% | -11.21% | 0.99% | 22.20% | 5.79% | -12.18% | Upgrade |
Cost of Revenue | 735.37 | 741.95 | 861.65 | 839.79 | 676.83 | 649.51 | Upgrade |
Gross Profit | 215.32 | 217.27 | 218.69 | 229.93 | 198.58 | 177.95 | Upgrade |
Selling, General & Admin | 144.98 | 144.66 | 150.29 | 152.02 | 138.22 | 117.44 | Upgrade |
Operating Expenses | 144.98 | 144.66 | 150.29 | 152.02 | 138.22 | 117.44 | Upgrade |
Operating Income | 70.34 | 72.61 | 68.4 | 77.91 | 60.36 | 60.51 | Upgrade |
Interest Expense | -20.3 | -21.51 | -26.19 | -18.28 | -15.42 | -19.46 | Upgrade |
Currency Exchange Gain (Loss) | 0.26 | 0.26 | 0.01 | 0.02 | 0.02 | -0.02 | Upgrade |
EBT Excluding Unusual Items | 50.3 | 51.36 | 42.22 | 59.65 | 44.96 | 41.02 | Upgrade |
Merger & Restructuring Charges | -1.87 | -1.87 | -1.04 | -3.49 | -3.74 | -4.35 | Upgrade |
Asset Writedown | - | - | - | -0.33 | -0.04 | - | Upgrade |
Legal Settlements | 10.37 | 9.8 | - | - | - | - | Upgrade |
Other Unusual Items | 12.73 | 12.73 | -7.07 | - | 7.9 | - | Upgrade |
Pretax Income | 71.54 | 72.03 | 34.11 | 65.82 | 49.08 | 36.67 | Upgrade |
Income Tax Expense | 12.68 | 11.87 | 2.43 | 11.09 | 6.83 | 7.87 | Upgrade |
Net Income | 58.86 | 60.16 | 31.68 | 54.73 | 42.25 | 28.8 | Upgrade |
Net Income to Common | 58.86 | 60.16 | 31.68 | 54.73 | 42.25 | 28.8 | Upgrade |
Net Income Growth | 71.17% | 89.93% | -42.12% | 29.54% | 46.69% | 179.93% | Upgrade |
Shares Outstanding (Basic) | 31 | 32 | 34 | 34 | 34 | 34 | Upgrade |
Shares Outstanding (Diluted) | 31 | 32 | 34 | 35 | 35 | 35 | Upgrade |
Shares Change (YoY) | -8.05% | -6.30% | -3.24% | -0.15% | 1.74% | 0.95% | Upgrade |
EPS (Basic) | 1.90 | 1.89 | 0.94 | 1.62 | 1.25 | 0.85 | Upgrade |
EPS (Diluted) | 1.90 | 1.89 | 0.93 | 1.56 | 1.20 | 0.83 | Upgrade |
EPS Growth | 87.54% | 103.23% | -40.38% | 30.00% | 44.58% | 176.67% | Upgrade |
Free Cash Flow | 37.97 | 66.78 | 160.27 | -96.83 | 8.37 | 94.05 | Upgrade |
Free Cash Flow Per Share | 1.23 | 2.10 | 4.72 | -2.76 | 0.24 | 2.72 | Upgrade |
Dividend Per Share | 0.438 | 0.430 | 0.409 | 0.318 | 0.245 | 0.173 | Upgrade |
Dividend Growth | 3.49% | 5.20% | 28.70% | 29.70% | 41.73% | -23.35% | Upgrade |
Gross Margin | 22.65% | 22.65% | 20.24% | 21.49% | 22.68% | 21.51% | Upgrade |
Operating Margin | 7.40% | 7.57% | 6.33% | 7.28% | 6.89% | 7.31% | Upgrade |
Profit Margin | 6.19% | 6.27% | 2.93% | 5.12% | 4.83% | 3.48% | Upgrade |
Free Cash Flow Margin | 3.99% | 6.96% | 14.84% | -9.05% | 0.96% | 11.37% | Upgrade |
EBITDA | 88.59 | 90.44 | 85.85 | 95.38 | 77.68 | 77.59 | Upgrade |
EBITDA Margin | 9.32% | 9.43% | 7.95% | 8.92% | 8.87% | 9.38% | Upgrade |
D&A For EBITDA | 18.25 | 17.83 | 17.45 | 17.47 | 17.32 | 17.09 | Upgrade |
EBIT | 70.34 | 72.61 | 68.4 | 77.91 | 60.36 | 60.51 | Upgrade |
EBIT Margin | 7.40% | 7.57% | 6.33% | 7.28% | 6.89% | 7.31% | Upgrade |
Effective Tax Rate | 17.72% | 16.48% | 7.14% | 16.85% | 13.92% | 21.46% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.